Oncolys BioPharma oncolys.com


Public list: Pharma Startups (4732) Cancer Therapeutics (1137)

Oncolys BioPharma develops breakthrough therapy and diagnostics in cancer treatment from early to late stage, including early detection, loco-regional therapy, prognostic test, and systemic treatments.

Oncolys BioPharma develops breakthrough therapy and diagnostics in cancer treatment from early to late stage, including early detection, loco-regional therapy, prognostic test, and systemic treatments.

Company (IPO / Went public)

Phone:

Fax:

Toranomon Towers Office
4-1-28 Toranomon, Minato-ku
Tokyo, 105-0001
Japan

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Oncolys BioPharma $64.4M Dec 9, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Oncolys BioPharma Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 3 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Method for producing 4′-ethynyl d4t Dec 26, 2008 Jun 09, 2015 Patent
Oncolytic virus replicating selectively in tumor cells Jul 19, 2010 Apr 24, 2012 Patent
Dr5 gene promoter and siah-1 gene promoter Apr 22, 2009 Jan 10, 2012 Patent
Telomelysin/gfp-expressing recombinant virus Jun 21, 2005 May 17, 2011 Patent
Molecularly targeted combination drug for tumor treatment and prevention Jan 25, 2014 Application